Consensus is for FY24 revenue $439.85M. The company’s revised guidance assumes that U.S. SCS trialing growth rates do not improve from the Q2. Lowers FY24 adjusted EBITDA view to (20M)-(18M) from (5M)-$2M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVRO: